Is it just a gentler kojic acid?

It is more stable and gentler, but it only acts like kojic acid if skin enzymes release the active from it. How efficiently that happens is genuinely disputed, which is the main caveat on this ingredient.

Why does it not turn brown like kojic acid?

The two fatty chains protect the reactive part of the molecule from oxygen and light. That stability is the clearest and least disputed benefit of the ester.

Will it fade melasma?

Melasma is persistent, recurs and usually needs a clinician-directed plan with sun protection at its centre. Treating it with a cosmetic brightener alone tends to disappoint.

Can I use it with vitamin C?

Yes. They are not in conflict and are often used together. Neither will do much without daily sun protection, which matters more than the pairing.

How long before I see anything?

Pigment changes slowly. Months rather than weeks, and only with consistent sun protection. Adding more actives to speed it up usually causes irritation, which makes pigmentation worse.

Kojic Dipalmitate — Ingredient Guide

How it works

Kojic acid is a fungal metabolite that inhibits tyrosinase, the enzyme that starts melanin synthesis. It has two well-known formulating problems: it oxidises readily, turning products brown, and it is a recognised irritant and sensitiser for some people.

Kojic dipalmitate is an attempt to solve both. Attaching two palmitic acid chains makes the molecule oil-soluble, much more stable to light and air, and gentler on contact. The design intent is a prodrug: esterases in the skin cleave the fatty chains, releasing kojic acid where it is wanted rather than in the jar.

The evidence

The stability improvement is not in question — it is straightforward chemistry and visible in products that do not discolour.

The conversion step is where the honest uncertainty sits. Whether skin esterases cleave kojic dipalmitate efficiently enough to deliver a useful amount of kojic acid is genuinely debated, and published data addressing it directly is limited. Most of the supporting material comes from ingredient suppliers rather than independent groups, and controlled human trials on the ester itself, as opposed to kojic acid or to multi-ingredient formulas, are scarce. Anyone presenting it as simply a better kojic acid is skipping that step. Alongside it, azelaic acid, tranexamic acid and vitamin C carry considerably more human evidence for uneven tone.

Suitability

Uneven tone and post-inflammatory marks, as one component of a longer approach
Formulas where kojic acid's instability or irritancy has been a problem
Oil-phase products — creams and oils — since it will not go into a water-based essence
Not for melasma self-treatment; melasma is stubborn, recurs, and needs a clinician's plan

Concentration

No established topical figure for the ester, and this entry does not carry one across from kojic acid, because the two are different molecules delivering different amounts of active. Regulatory limits on kojic acid exist and vary by jurisdiction; whether and how they apply to the ester is a question for the current rules where you live rather than for a summary written elsewhere.

Conflicts & combinations

No documented conflicts. It is commonly paired with niacinamide and with vitamin E, which also helps protect the oil phase it sits in. As with every ingredient aimed at pigment, the result depends far more on daily sun protection than on the ingredient: without it, pigment that is being broken down is simultaneously being remade, and no brightening ingredient wins that race. Any brightening routine also needs patience — visible change takes months, and stacking more actives to speed it up produces irritation, which produces more pigment.